Vijaya Diagnost.
Diagnostics & Research · VIJAYA
Mid CapHealthcareHigh Growth
Supriti Reddy
Managing Director and CEO · Pragmatic
Company DNA
Founder-Centric
About
Vijaya Diagnost. is a Mid Cap company in the Healthcare sector, listed on NSE as VIJAYA. With a market cap of ₹10K Cr and revenue of ₹681 Cr, it is currently in the High Growth phase. Known for its Founder-Centric culture and Fast-Follower approach to innovation, the company operates at a Startup-Speed pace. Deeply linked to promoter vision for healthcare service delivery; founder-led governance model is prominent. Its strategic mandate: Scaling the diagnostic chain requires balancing rapid regional network growth with consistent service quality and patient-centric delivery.
FAQ
What kind of company is Vijaya Diagnost.?
Vijaya Diagnost. is a Mid Cap Healthcare company (VIJAYA) in the High Growth phase with a market cap of ₹10K Cr. It is classified as Founder-Centric in culture.
What is Vijaya Diagnost.'s culture and work environment like?
Vijaya Diagnost. has a Founder-Centric culture with Fast-Follower innovation DNA and a Startup-Speed pace of execution. Employee brand: Demanding Machine. Customer relationship style: Mass-Consumer. Deeply linked to promoter vision for healthcare service delivery; founder-led governance model is prominent.
Who leads Vijaya Diagnost.?
Vijaya Diagnost. is led by Supriti Reddy (Managing Director and CEO), a Pragmatic leader with 22 years of experience.
What are Vijaya Diagnost.'s financials?
Vijaya Diagnost. reported revenue of ₹681 Cr in FY25 with a 5-year revenue CAGR of 13.8%. Operating margin: 29.8%. Market cap: ₹10K Cr.
Culture & Strategy
CultureFounder-Centric
InnovationFast-Follower
PaceStartup-Speed
PurposePurpose-Blended
CustomerMass-Consumer
EmployeeDemanding Machine
BrandValue-Champion
LifecycleHigh Growth
Deeply linked to promoter vision for healthcare service delivery; founder-led governance model is prominent.
Mandate
Scaling the diagnostic chain requires balancing rapid regional network growth with consistent service quality and patient-centric delivery.
Scaling the diagnostic chain requires balancing rapid regional network growth with consistent service quality and patient-centric delivery.
Financials
Revenue FY25₹681 Cr
PAT FY25₹143 Cr
Rev CAGR 5Y13.8%
OPM29.8%
NPM21%
ROE18%
ROCE18.2%
P/E60.2
Fwd P/E45.3
P/B11.1
D/E42.2
Mkt Cap₹10K Cr
Promoter52.5%
Institutional35.7%
Similar Culture
Could You Lead Vijaya Diagnost.?
Take the Genome Benchmark →